Edward Pershing - Net Worth and Insider Trading

Edward Pershing Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Edward Pershing owns 1 companies in total, including Provectus Biopharmaceuticals Inc (PVCT) .

Click here to see the complete history of Edward Pershing’s form 4 insider trades.

Insider Ownership Summary of Edward Pershing

Ticker Comapny Transaction Date Type of Owner
PVCT Provectus Biopharmaceuticals Inc 2018-04-27 director

Edward Pershing Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Edward Pershing Ownership Network

Ownership Network List of Edward Pershing

No Data

Ownership Network Relation of Edward Pershing

Insider Network Chart

Edward Pershing Owned Company Details

What does Provectus Biopharmaceuticals Inc do?

Who are the key executives at Provectus Biopharmaceuticals Inc?

Edward Pershing is the director of Provectus Biopharmaceuticals Inc. Other key executives at Provectus Biopharmaceuticals Inc include 10 percent owner Jeffrey Allen Morris , Chief Financial Officer Heather Raines , and See Remarks John R Glass .

Provectus Biopharmaceuticals Inc (PVCT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Provectus Biopharmaceuticals Inc (PVCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Provectus Biopharmaceuticals Inc (PVCT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Provectus Biopharmaceuticals Inc (PVCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Provectus Biopharmaceuticals Inc Insider Transactions

No Available Data

Edward Pershing Mailing Address

Above is the net worth, insider trading, and ownership report for Edward Pershing. You might contact Edward Pershing via mailing address: 2220 Southerland Ave, Knoxville Tn 37919.

Discussions on Edward Pershing

No discussions yet.